Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study

Korkmaz, Levent; COŞKUN, HASAN; Dane, Faysal; KARABULUT, BÜLENT; Karaagac, Mustafa; ÇABUK, DEVRİM; Karabulut, Senem; Aykan, Nuri; Doruk, Hatice; Avci, Nilufer; Turhal, Nazim; Artac, Mehmet

doi:10.1016/j.suronc.2018.05.032

Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group study

Korkmaz L., COŞKUN H. Ş., Dane F., KARABULUT B., Karaagac M., ÇABUK D., ...More

SURGICAL ONCOLOGY-OXFORD, vol.27, no.3, pp.485-489, 2018 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 27 Issue: 3
Publication Date: 2018
Doi Number: 10.1016/j.suronc.2018.05.032
Journal Name: SURGICAL ONCOLOGY-OXFORD
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.485-489
Keywords: Metastatic colorectal cancer, Bevacizumab, Primary tumor resection, UNRESECTABLE SYNCHRONOUS METASTASES, RANDOMIZED PHASE-III, POOLED ANALYSIS, BEVACIZUMAB, CHEMOTHERAPY, COMBINATION, SURVIVAL, EFFICACY, SURGERY, THERAPY
Akdeniz University Affiliated: Yes

Abstract

Purpose: We aimed to investigate the prognostic effect of primary tumor resection (PTR) prior to bevacizumab-based treatments in unresectable metastatic colorectal cancer (mCRC).